The registration is now closed and complete. If you have any questions, please contact email@example.com
The Oncopole is organizing its first annual symposium on Nov. 1-2 in Montreal. This event will present a number of new research initiatives supported by Oncopole as well as a series of keynote speakers on topics such as drug development, recent advances in immuno-oncology, cancer research and data sharing in the era of personalized medicine. We are looking forward to foster discussions and networking between researchers, students, leaders in the field and various partners all dedicated to a better research community to lead the fight against cancer.
This year’s symposium takes place at the Hyatt Regency Montreal, located downtown and easily accessible.
Dr. William Dalton
Founder and Executive Chair of M2Gen, Moffitt Cancer Center
Dr. Pierre Hainaut
Director of Institute for Advanced Biosciences, Inserm-CNRS-
Université Grenoble Alpes
Dr. Laszlo Radvanyi
President and Scientific Director, Ontario Institute for Cancer Research
Dr. Dmitriy Zamarin
Medical Oncologist, Memorial Sloan-Kettering Cancer Center
Gynecologic Medical Oncology Immunotherapeutic Service
Dr. Rima Al-awar
Director and Senior Principal Investigator, Drug Discovery Program,
Ontario Institute for Cancer Research
Dr. Gregory Simon
President, Biden Cancer Initiative
You can download our preliminary program in PDF format.
Registration for the symposium is free but places are limited.
Students and post-doctoral researchers are invited to submit an abstract before October 10th for poster presentations to be held on Nov. 2nd.
For more information about Oncopole, click here.